Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

40 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
MAD2γ, a novel MAD2 isoform, reduces mitotic arrest and is associated with resistance in testicular germ cell tumors.
López-Saavedra A, Ramírez-Otero M, Díaz-Chávez J, Cáceres-Gutiérrez R, Justo-Garrido M, Andonegui MA, Mendoza J, Downie-Ruíz Á, Cortés-González C, Reynoso N, Castro-Hernández C, Domínguez-Gómez G, Santibáñez M, Fabián-Morales E, Pruefer F, Luna-Maldonado F, González-Barrios R, Herrera LA. López-Saavedra A, et al. Cell Cycle. 2016 Aug 2;15(15):2066-76. doi: 10.1080/15384101.2016.1198863. Epub 2016 Jun 17. Cell Cycle. 2016. PMID: 27315568 Free PMC article.
The epigenetic factor BORIS (CTCFL) controls the androgen receptor regulatory network in ovarian cancer.
Salgado-Albarrán M, González-Barrios R, Guerra-Calderas L, Alcaraz N, Estefanía Sánchez-Correa T, Castro-Hernández C, Sánchez-Pérez Y, Aréchaga-Ocampo E, García-Carrancá A, Cantú de León D, Herrera LA, Baumbach J, Soto-Reyes E. Salgado-Albarrán M, et al. Oncogenesis. 2019 Aug 12;8(8):41. doi: 10.1038/s41389-019-0150-2. Oncogenesis. 2019. PMID: 31406110 Free PMC article.
The Promising Role of miR-21 as a Cancer Biomarker and Its Importance in RNA-Based Therapeutics.
Bautista-Sánchez D, Arriaga-Canon C, Pedroza-Torres A, De La Rosa-Velázquez IA, González-Barrios R, Contreras-Espinosa L, Montiel-Manríquez R, Castro-Hernández C, Fragoso-Ontiveros V, Álvarez-Gómez RM, Herrera LA. Bautista-Sánchez D, et al. Mol Ther Nucleic Acids. 2020 Jun 5;20:409-420. doi: 10.1016/j.omtn.2020.03.003. Epub 2020 Mar 13. Mol Ther Nucleic Acids. 2020. PMID: 32244168 Free PMC article. Review.
Transcriptome Analysis Identifies GATA3-AS1 as a Long Noncoding RNA Associated with Resistance to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer Patients.
Contreras-Espinosa L, Alcaraz N, De La Rosa-Velázquez IA, Díaz-Chávez J, Cabrera-Galeana P, Rebollar-Vega R, Reynoso-Noverón N, Maldonado-Martínez HA, González-Barrios R, Montiel-Manríquez R, Bautista-Sánchez D, Castro-Hernández C, Alvarez-Gomez RM, Jiménez-Trejo F, Tapia-Rodríguez M, García-Gordillo JA, Pérez-Rosas A, Bargallo-Rocha E, Arriaga-Canon C, Herrera LA. Contreras-Espinosa L, et al. J Mol Diagn. 2021 Oct;23(10):1306-1323. doi: 10.1016/j.jmoldx.2021.07.014. Epub 2021 Aug 4. J Mol Diagn. 2021. PMID: 34358678 Free article.
MPS1 is involved in the HPV16-E7-mediated centrosomes amplification.
Alfaro-Mora Y, Domínguez-Gómez G, Cáceres-Gutiérrez RE, Tolentino-García L, Herrera LA, Castro-Hernández C, Bermúdez-Cruz RM, Díaz-Chávez J. Alfaro-Mora Y, et al. Cell Div. 2021 Nov 4;16(1):6. doi: 10.1186/s13008-021-00074-9. Cell Div. 2021. PMID: 34736484 Free PMC article.
Large-scale topological disruption of chromosome territories 9 and 22 is associated with nonresponse to treatment in CML.
Fabian-Morales E, Vallejo-Escamilla D, Gudiño A, Rodríguez A, González-Barrios R, Rodríguez Torres YL, Castro Hernández C, de la Torre-Luján AH, Oliva-Rico DA, Ornelas Guzmán EC, López Saavedra A, Frias S, Herrera LA. Fabian-Morales E, et al. Int J Cancer. 2022 May 1;150(9):1455-1470. doi: 10.1002/ijc.33903. Epub 2021 Dec 29. Int J Cancer. 2022. PMID: 34913480 Free PMC article.
The promising role of new molecular biomarkers in prostate cancer: from coding and non-coding genes to artificial intelligence approaches.
Alarcón-Zendejas AP, Scavuzzo A, Jiménez-Ríos MA, Álvarez-Gómez RM, Montiel-Manríquez R, Castro-Hernández C, Jiménez-Dávila MA, Pérez-Montiel D, González-Barrios R, Jiménez-Trejo F, Arriaga-Canon C, Herrera LA. Alarcón-Zendejas AP, et al. Prostate Cancer Prostatic Dis. 2022 Sep;25(3):431-443. doi: 10.1038/s41391-022-00537-2. Epub 2022 Apr 14. Prostate Cancer Prostatic Dis. 2022. PMID: 35422101 Free PMC article. Review.
40 results